Market
Overview:
The report also studies the impact of various
technologies on it. It is an efficient technology backed by top-class IT
infrastructure. Digitalization made its percolation easier. Rising sale of
smartphones and tablets are going to spur the demand for the same. Increasing care
for personal health, better disposal income, easy inclusion of wireless
technologies, portability, cost-effective features, change in lifestyle, and
others can ensure strong growth for the mHealth market.
The study of the mHealth
Market Growth, as conducted by Market Research Future (MRFR) reveals
that it has a possibility of surpassing a valuation of USD 21.71 billion by
2022. This process would see a rise by a significant CAGR of 36.5% during the
forecast period (2016-2022).
Competitive
Analysis:
The global mHealth market to gain significant backing
from companies like Alivecor, INC,
Apple, INC, Agamatrix, INC, AT&T, INC, Athenahealth INC, GE Healthcare,
Google INC, Biotelemetry INC. (CARDIONET), Johnson & Johnson, Jawbone INC,
Philips Healthcare, Laboratory Corporation of America Holdings
Segmentation:
The global mHealth market report includes several
segments that have been studied properly to understand dynamics dominating the
market. This study includes segments on the basis of therapeutics and
applications.
By therapeutics, the report on the global mHealth
market can be segmented into fitness & lifestyle therapeutics, respiratory,
mental and neurological disorders, diabetes, and others. The rise of diabetes
among people is going to trigger further growth for the mHealth market.
By application, the global market report on mHealth
can be segmented into diagnosis & treatment, monitoring applications,
wellness & prevention, healthcare management, education and awareness,
remote data collection, and others. The remote data collection segment is
aiding the research sector in a significant way. The monitoring segment has a
hold over 61.8% of the global market.
Regional
Analysis:
The global market for mHealth has been analyzed in the
report. It includes several aspects of the demographic challenges to understand
how far the players can benefit from various growth factors.
The Americas is slated to lead the mHealth market by
creating ample scope for growth through funding for research and development,
and other marketing strategies. The nod it is getting from the government has
ensured significant progress for the market in the coming days. IT
infrastructure is getting better and a lot of caregivers would help the market
to increase by creating high intake. The regional market covers almost 34% of
the entire market share. In Europe, the market is getting similar
acknowledgments and it is on an upward track. High investment for research and
development and better backup from technological inclusion are expected to
ensure the growth of the market. This regional market can grow with 35.65% CAGR
during the forecast period.
The Asia Pacific region is on a track where achieving
the highest CAGR is quite possible. This is due to the growing investment from
several economies to ensure better healthcare infrastructure, to reach distant
corners where easy healthcare facilities are not available, and also, they can
avail it at a cheaper rate. India, China, Thailand, Japan, and Australia are
helming the market by launching different innovations.
Industry
News:
In January 2020, the Rady Children’s Institute for
Genomic Medicine (RCIGM) announced that they are planning on investing in
drones to collect genomic samples to speed up the procedure of treatment. They
believe that this would significantly boost the treatment of critically ill
children.
NOTE :
Our team of researchers are studying Covid19 and
its impact on various industry verticals and wherever required we will be
considering covid19 footprints for a better
analysis of markets and industries. Cordially get in touch for more details.
Comments
Post a Comment